Emerald Mutual Fund Advisers Trust Passage Bio, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$9.73 - $15.52 $2.82 Million - $4.5 Million	-290,213 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$12.44 - $19.45 $93,300 - $145,875	-7,500 Reduced 2.52%	290,213 $3.84 Million
Q1 2021 Apr 29, 2021	BUY	$16.24 - $29.83 $2.59 Million - $4.76 Million	159,552 Added 115.48%	297,713 $5.2 Million
Q4 2020 Jan 29, 2021	SELL	$14.28 - $29.73 $2.69 Million - $5.61 Million	-188,712 Reduced 57.73%	138,161 $3.53 Million
Q2 2020 Jul 28, 2020	BUY	$14.59 - $36.07 $85,497 - $211,370	5,860 Added 1.83%	326,873 $8.93 Million
Q1 2020 Apr 30, 2020	BUY	$8.86 - $22.2 $2.84 Million - $7.13 Million	321,013 New	321,013 $5.06 Million

36.4M

50.3K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $20.7M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.